Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Appointed CFO Quarterly results Consulting agrmnt Director departure Appointed director
|
NEPHROS INC (NEPH)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/09/2023 |
8-K
| Quarterly results |
03/08/2023 |
8-K
| Quarterly results |
11/02/2022 |
8-K
| Quarterly results |
08/10/2022 |
8-K
| Quarterly results |
05/04/2022 |
8-K
| Quarterly results |
02/23/2022 |
8-K
| Quarterly results |
03/01/2021 |
8-K
| Quarterly results |
08/05/2020 |
8-K
| Quarterly results |
05/07/2020 |
8-K
| Quarterly results |
02/27/2020 |
8-K
| Quarterly results |
11/06/2019 |
8-K
| Quarterly results |
08/07/2019 |
8-K
| Quarterly results |
08/02/2019 |
8-K
| Quarterly results |
05/08/2019 |
8-K
| Quarterly results |
11/08/2012 |
8-K
| Quarterly results
Docs:
|
"Nephros Reports Third Quarter 2012 Financial Results RIVER EDGE, NJ, November 8, 2012 /PR Newswire-FirstCall/ -- Nephros, Inc. , a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced today financial results for the three and nine months ended September 30, 2012. Recent Highlights · Year-to-date ultrafilter sales to our three target markets of over $800,000 vs. approximately $600,000 for full year 2011 · First shipment of over 1,300 ultrafilters to U.S. Military · First European ultrafilter order processed through Nephros International · Appointed Frank Zumbo, Denise Pappas and Stephen Bob as Regional Sales Managers to focus on ultrafilters in dialysis and hospital markets · New distr..." |
|
11/13/2007 |
8-K
| Quarterly results |
08/13/2007 |
8-K
| Quarterly results |
05/15/2007 |
8-K
| Quarterly results |
11/14/2005 |
8-K
| Quarterly results |
08/15/2005 |
8-K
| Quarterly results |
|
|